文献速递炎症性肠病

炎症性肠病诊断前血清代谢组变化

Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-02-17

丹麦PREDICT队列纳入169例IBD患者和169例匹配对照,进行非靶向血清代谢组检测,发现诊断前多达14年已有1206种代谢物显著改变,以克罗恩病为著,代谢物预测CD的AUC为0.78。

要点

  • IBD诊断前14年即可检测到血清代谢物改变,支持长临床前期。
  • 克罗恩病诊断前882种代谢物改变,富含类花生酸和脂肪酸等炎症相关脂质。
  • 代谢物预测克罗恩病的AUC为0.78。

核心结论

  • IBD诊断前超过1000种代谢物发生改变,以日后克罗恩病者最明显,提示存在长临床前期。

研究设计与样本

  • 丹麦PREDICT队列通过全国登记与生物库链接纳入诊断前血清样本,169例IBD(72例CD、97例UC)和169例匹配对照。
  • 采用非靶向代谢组学分析诊断前血清代谢物变化、变化时间及预测IBD能力。

主要发现

  • 诊断前共1206种代谢物显著改变(Padj < .05)。
  • CD诊断前882种代谢物显著改变,类花生酸、脂肪酸和甘油磷酸胆碱显著富集,包括炎症相关生物活性脂质。
  • 882种中有570种(65%)与UC也存在名义关联。
  • 代谢物改变可早至诊断前14年,预测CD的AUC为0.78。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Serum metabolites reflect genetics, environmental exposures, and the gut microbiome. We analyzed changes in the serum metabolome up to 14 years before the diagnosis of inflammatory bowel disease (IBD) to identify early biomarkers and uncover pathophysiological changes during the pre-diagnostic phase. METHODS: The Danish PREDICT cohort was established by cross-linking nationwide health registries with the Danish National Biobank to identify patients with pre-diagnostic serum samples. A total of 169 individuals with IBD (72 Crohn's disease [CD]; 97 ulcerative colitis [UC]) and 169 matched controls were included for untargeted profiling to investigate pre-diagnostic alterations in the serum metabolome, timing of metabolomic changes, and their ability to predict IBD. RESULTS: A total of 1206 metabolites were significantly altered prior to IBD diagnosis (Padj < .05). For CD, 882 metabolites were significantly altered, with significant enrichment of eicosanoids, fatty acids, and glycerophosphocholines, including bioactive lipids linked to inflammation. Of these 882 metabolites, 570 (65%) were also nominally associated with UC. Metabolites were altered up to 14 years prior to diagnosis and predicted CD with an area under the receiver operating characteristic curve of 0.78. CONCLUSIONS: We identified alterations in >1000 metabolites up to 14 years prior to diagnosis of IBD, most pronounced in individuals with later CD. Our findings suggest a long pre-clinical phase of IBD, where mucosal breakdown contributes to production of inflammation-modulating lipids.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lemser CE, Koziol A, Boelt SG, et al. Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2026. PMID: 41713825. doi:10.1016/j.cgh.2026.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。